These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28089966)

  • 41. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Points to Consider: Best Practices to Identify Particle Entry Routes along the Manufacturing Process for Parenteral Formulations.
    Anger S; Begat C; Crnko V; Fantozzi G; Farach W; Fitzpatrick S; Gallagher B; Huelsmann S; Kinsey P; Langlade V; Lefevre G; Legendre E; McLean K; Miller J; Patel R; Perry A; Soukiassian H; Stanton A; Streich D; Timmons C; Vaneylen D; van Hoose T; Wildling L; Windover M
    PDA J Pharm Sci Technol; 2019; 73(6):635-647. PubMed ID: 31420504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exposure assessment of pharmaceutical powders based on an environmental monitoring method: a pilot study.
    Demircan Yildirim F; Ekmekci I
    Med Pr; 2020 Dec; 71(6):649-663. PubMed ID: 33107497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hazard analyses of airborne contamination in clean rooms--application of a method for limitation of risks.
    Ljungqvist B; Reinmüller B
    PDA J Pharm Sci Technol; 1995; 49(5):239-43. PubMed ID: 7489198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microbial identification strategies in the pharmaceutical industry.
    Cundell AM
    PDA J Pharm Sci Technol; 2006; 60(2):111-23. PubMed ID: 16696194
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study of psychrophilic and psychrotolerant micro-organisms isolated in cold rooms used for pharmaceutical processing.
    Sandle T; Skinner K
    J Appl Microbiol; 2013 Apr; 114(4):1166-74. PubMed ID: 23216715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Top ten hot topics in parenteral science and technology.
    Akers MJ; Nail SL; Saffell-Clemmer W
    PDA J Pharm Sci Technol; 2007; 61(5):337-61. PubMed ID: 18047174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Good design practices for an integrated containment and production system for advanced therapies.
    Zanini C; Severina F; Lando G; Fanizza C; Cesana E; Desidera D; Bonifacio M
    Biotechnol Bioeng; 2020 Aug; 117(8):2319-2330. PubMed ID: 32374459
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk reduction in biotherapeutic products.
    Ill CR; Dehghani H
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):296-304. PubMed ID: 19333875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation Studies for Microbial Contamination and Control of Contaminants.
    Shintani H
    Biocontrol Sci; 2015; 20(3):161-70. PubMed ID: 26412695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
    Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N
    J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Environmental Monitoring in a Pharmaceutical Manufacturing Facility Using a Culture Independent Approach].
    Kawai M
    Yakugaku Zasshi; 2022; 142(1):33-37. PubMed ID: 34980749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loading and unloading of freeze-dryers: airborne contamination risks for aseptically manufactured sterile drug products.
    Ljungqvist B; Reinmüller B
    PDA J Pharm Sci Technol; 2007; 61(1):44-50. PubMed ID: 17390703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities.
    Weller T; Kragseth R; Dullinger R; Illum H; Perry A
    Int J Pharm Compd; 2015; 19(3):182-92. PubMed ID: 26714359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quality Assurance and Quality Control, Part 2.
    Akers MJ
    Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmaceutical quality by design: product and process development, understanding, and control.
    Yu LX
    Pharm Res; 2008 Apr; 25(4):781-91. PubMed ID: 18185986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of surface-enhanced Raman spectroscopy (SERS) for cleaning verification in pharmaceutical manufacture.
    Corrigan DK; Cauchi M; Piletsky S; Mccrossen S
    PDA J Pharm Sci Technol; 2009; 63(6):568-74. PubMed ID: 20169863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Microbiological in-process control in drug manufacture].
    Seyfarth VH
    Arzneimittelforschung; 1985; 35(1A):205-16. PubMed ID: 4039162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative and qualitative analysis of microorganisms in an assisted reproductive technology facility.
    Herlong JL; Reubish K; Higdon HL; Boone WR
    Fertil Steril; 2008 Apr; 89(4):847-53. PubMed ID: 17678906
    [TBL] [Abstract][Full Text] [Related]  

  • 60. July-August 2020 Issue.
    Levy R
    PDA J Pharm Sci Technol; 2020; 74(4):367. PubMed ID: 32737241
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.